Statin induced necrotizing autoimmune myopathy.

Area of Science:

• Neurology
• Immunology
• Pharmacology

Background:

• Statin induced necrotizing autoimmune myopathy (SINAM) is a severe form of statin myotoxicity.
• It presents with proximal muscle weakness, elevated creatine kinase, and persistent symptoms post-statin discontinuation.

Purpose of the Study:

• To characterize SINAM, an autoimmune disorder associated with anti-3-hydroxy-3-methyglutaryl-coenzyme A reductase (HMGCR) antibodies.
• To highlight the importance of prompt diagnosis and immunosuppressive therapy for improved clinical outcomes.

Main Methods:

• Review of clinical features, pathological findings (muscle biopsy), and immunological markers (anti-HMGCR antibodies).
• Analysis of treatment response to immunosuppressive therapy.

Main Results:

• SINAM is characterized by marked muscle fiber necrosis with minimal inflammation.
• Anti-HMGCR antibody titer is a useful marker for treatment response.
• Anti-HMGCR positive myopathies can occur without statin exposure, particularly in younger individuals.

Conclusions:

• SINAM requires prompt recognition and management with immunosuppressive therapy for significant clinical improvement.
• Further research is needed to understand pathogenesis and establish evidence-based management guidelines.